Updates in HER2+ mBC


Case Study Discussion on HER2+ MBC: Trastuzumab Deruxtecan in Heavily Pretreated Patient, Management of Interstitial Lung Disease

254 views
January 21, 2021
Comments 0
Login to view comments. Click here to Login